Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-06-07
1998-08-18
Loring, Susan A.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303882, 5303884, 5303871, 530866, 435335, 4241331, 4241451, C07K 1600, C12N 506, A61K 39395
Patent
active
057959676
ABSTRACT:
Tumor necrosis factor antagonists are administered in therapeutically effective doses to suppress inflammatory immune-potentiated events. The antagonists of this invention typically are selected from among several classes but preferably are neutralizing antibodies directed against tumor necrosis factor. The antagonists are useful in suppressing transplantation immunity and in the treatment of autoimmune diseases.
REFERENCES:
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4359415 (1982-11-01), Sloane
patent: 4411994 (1983-10-01), Gilbert et al.
patent: 4447355 (1984-05-01), Sakamoto
patent: 4457916 (1984-07-01), Hayashi et al.
patent: 4481137 (1984-11-01), Ohnishi et al.
patent: 4485038 (1984-11-01), Chadha et al.
patent: 4495282 (1985-01-01), Ohnishi et al.
patent: 4544546 (1985-10-01), Wang et al.
patent: 4677063 (1987-06-01), Mark et al.
patent: 4677064 (1987-06-01), Mark et al.
patent: 4677197 (1987-06-01), Lin et al.
patent: 4752575 (1988-06-01), Granger et al.
patent: 4758549 (1988-07-01), Mitsuhashi et al.
patent: 4879226 (1989-11-01), Wallace et al.
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5288852 (1994-02-01), Yamada et al.
patent: 5654407 (1997-08-01), Boyle et al.
patent: 5672347 (1997-09-01), Aggarwal et al.
patent: 5698419 (1997-12-01), Wolpe et al.
Lerner, Richard A., Nature, 299: 592-596, Oct. 1982.
Sevier, E. D. et al., Clin Chem, 27(11): 1797-1806, 1981.
Williamson, B. D. et al, PNAS, 80: 5397-5401, Sep. 1983.
Haidaris, C.G. et al., Inf. & Immun, 42(1): 385-393, Oct. 1983.
Adams et al., "Effector Mechanisms of Cytolytically Activated Macrophages" J. of Immunology 124(1):293-300 (1980).
Adelman et al., "In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone" DNA 2(3):183-193 (1983).
Aggarwal et al., "Chemical and Biological Properties of Human Lymphotoxin" Thymic Hormones & Lymphokines, Goldstein, Plenum Publishing pp. 235-245 (1984).
Aggarwal et al., "Human Tumor Necrosis Factor" Journal of Biological Chemistry 260(4):2345-2354 (1985).
Aggarwal et al., "Human tumor necrosis factor. Production, purification, and characterization" Chemical Abstracts 102(15):130173u (1985).
Aksamit et al., "Macrophage cell lines produce a cytotoxin" J. Immunol. 122(5):1785-1790 (1979).
Armstrong et al., "Isolation and Initial Characterization of Tumoricidal Monokine(s) From the Human Monocytic Leukemia Cell Line THP-1" JNCI 74(1):1-9 (Jan. 1985).
Benton et al., "Screening .lambda.gt recombinant clones by hybridization to single plaques in situ" Science 196(4286):180-182 (1977).
Beutler et al., "Cachectin and Tumor Necrosis Factor as Two Sides of the Same Biological Coin" Nature 320:584-588 (Apr. 17, 1986).
Beutler, B. et al., "Identity of tumor necrosis factor and the macrophage-secreted factor cachectin" Nature 316:552-554 (1985).
Beutler, B. et al., "Passive Immunization Against Cachectin/Tumor Necrosis Factor Proteins Mice from Lethal Effect of Endotoxin" Science 229:869-871 (1985).
Birnboim and Doly, "A Rapid Alkaline Extraction Procedure for Screening Recombinant Plasmid DNA" Nucleic Acids Research 7:1513-1523 (1980).
Broxmeyer et al., "The Suppressive Influences of Human Tumor Necrosis Factors on Bone Marrow Hematopoietic Progenitor Cells From Normal Donors and Patients with Leukemia: Synergism of Tumor Necrosis Factor and Interferon-.gamma." Journal of Immunology 136(12):4487-4495 (Jun. 15, 1986).
Buessow et al., "Tumoricidal activity of an acute promyelocytic leukemia cell line (HL-600) is augmented by human interferon .alpha." Leukemia Research 8(5):801-811 (1984).
Carswell et al., "An Endotoxin-induced Serum Factor That Causes Necrosis of Tumors" Proc. Natl. Acad. Sci. USA 72(9):3666-3670 (1975).
Cerletti et al., "Lymphotoxin from the human lymphoblastoid cell line LuK II: Isolation, characterization and N-terminal sequence determination" Lymphokine Research 6:Abstract 1452 (1987).
Cross et al., "Stimulation of polymorphonuclear leukocyte bactericidal activity by supernatants of activated human mononuclear cells" Infection and Immunity 22(2):502-507 (1978).
De St. Groth et al., "Production of Monoclonal Antibodies: Strategy and Tactics" J. Immunol. Methods 35:1-21 (1980).
Degliantoni et al., "Natural Killer (NK) Cell-Derived Hematopoietic Colony-Inhibiting Activity and NK Cytotoxic Factor" Journal of Experimental Medicine 162:1512-1530 (1985).
Dinarello et al., "Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1" Journal of Experimental Medicine 163(6):1433-1450 (1986).
Evans, "Lymphotoxin-An Immunologic Hormone with Anticarcinogenic and Antitumor Activity" Cancer Immunol. Immunother. 12:181-190 (1982).
Ezekowitz et al., "Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement" J. Clin. Invest. 76(6):2368-2376 (1985).
Fisch et al., "In vitro production of rabbit macrophage tumor and cytotoxin" Chemical Abstracts 99:137978p (1983).
Flick et al., "Tumor Necrosis Factor" Biological Response Modifiers, Torrence, P. (ed.), Chapter 8, pp. 171-218 (1985).
Fujiwara et al., "Increased Interleukin-1 Production and Monocyte Suppressor Cell Activity Assosiated with Human Tuberculosis" Am. Rev. Respir. Dis. 133:73-77 (1986).
Gamble et al., "Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor" Proc. Natl. Acad. Sci. 82(24):8667-8671 (1985).
Granger et al., "The Human LT System. I. Physical-chemical Heterogeneity of LT Molecules Released by Mitogen Activated Human Lymphocytes In Vitro" Cellular Immunology 38(2):388-402 (Jul. 1978).
Granger et al., "LT Molecules form a Subunit System for Cell Toxins" Biochemical Characterization of Lymphokines, De Weck et al. (eds.) pp. 279-283 (1980).
Granger et al., "Receptor and Non-receptor Associated, Lymphocyte-derived Cell-lytic Molecules" Cellular Responses to Molecular Modulators, Mozes et al. (eds.) pp. 287-310 (1981).
Gray et al., "Cloning and Expression of cDNA for Human Lymphotoxin, a Lymphokine with Tumor Necrosis Activity" Nature 312:721-724 (1984).
Green et al., "Corynebacterium parvum as the Priming Agent in the Production of Tumor Necrosis Factor in the Mouse" JNCI 59(5):1519-1522 (1977).
Green et al., "Evidence for the presence of an antitumor factor in serum of normal animals" Cancer Letters 6:235-240 (1979).
Green et al., "Human-serum factor inhibits human tumors in vitro and in vivo," Journal of Cell Biology 79:67 #CU306 (1978).
Green et al., "Murine Tumor Necrosis-Inducing Factor: Purification and Effects of Myelomonocytic Leukemia Cells" JNCI 68(6):997-1003 (1982).
Green et al., "Partial purification of a serum factor that causes necrosis of tumors" Proc. Natl. Acad. Sci. 73(2):381-385 (1976).
Green et al., "A protein fraction (NHG) from serum of normal humans which is cytotoxic for HELA cells in culture" Cancer Letters 11:345-350 (1981).
Haidaris, C.G. et al., "Serum Containing Tumor Necrosis Factor is Cytotoxic for the Human Malaria Parasite Plasmodium falciparum" Infection and Immunity 42(1):385-393 (1983).
Hall et al., "Induction of Cytotoxic Effector Activity in the HL-60 Promyelocytic Cell Line by Incubation with Phorbol Myristate Acetate: A Model System of Human Spontaneous Monocyte-Mediated" Cellular Immunology 76:58-68 (1983).
Hammerstrom, "Soluble Cytostatic Factor(s) Released from Human Monocytes" Scand. J. Immunol. 15:311-318 (1982).
Haranaka & Satomi, "Cytotoxic Activity of Tumor Necrosis Factor (TNF) on Human Cancer Cells in vitro" Japan J. Exp. Med. 51(3):191-194 (1981).
Helson et al., "Effect of tumor necrosis factor on cultured human melanoma cells" Nature 258:731-732 (1975).
Helson et al., "Effects of murine tumor necrosis factor on heterotransplanted human tumors" Expl. Cell Biol. 47:53-60 (1979).
Itakura et al., "Expression in Escherichia coli of a Chemically Synthesized Gene for the Hormone Somatostatin" Science 198:1056-1063 (1977).
Johnson et al., "Lymphotoxin formation by lymphocytes and muscle in polymyo
Aggarwal Bharat B.
Palladino Michael A.
Shalaby Mohamed R.
Genentech Inc.
Loring Susan A.
Marschang Diane L.
LandOfFree
Tumor necrosis factor antagonists and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor necrosis factor antagonists and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor necrosis factor antagonists and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1115703